These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9762248)

  • 1. [What histo-prognostic factors are useful in making a therapeutic decision in colonic cancer?].
    Piard F; Monges G
    Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S115-25. PubMed ID: 9762248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Which histo-prognostic factors are useful for a therapeutic decision in colon cancer?].
    Piard F; Monges G
    Ann Pathol; 1998 Nov; 18(5):404-14. PubMed ID: 9864576
    [No Abstract]   [Full Text] [Related]  

  • 3. [Which techniques are useful for diagnosis of colonic cancer and for therapeutic choice?].
    Siproudhis L
    Gastroenterol Clin Biol; 1998 Mar; 22(3 Suppl):S226-35. PubMed ID: 9762259
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome prediction and the future of the TNM staging system.
    Burke HB
    J Natl Cancer Inst; 2004 Oct; 96(19):1408-9. PubMed ID: 15467022
    [No Abstract]   [Full Text] [Related]  

  • 5. Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.
    Poincloux L; Durando X; Seitz JF; Thivat E; Bardou VJ; Giovannini MH; Parriaux D; Barriere N; Giovannini M; Delpero JR; Monges G
    Surg Oncol; 2009 Dec; 18(4):357-65. PubMed ID: 19027288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current issues in adjuvant treatment of stage II colon cancer.
    André T; Sargent D; Tabernero J; O'Connell M; Buyse M; Sobrero A; Misset JL; Boni C; de Gramont A
    Ann Surg Oncol; 2006 Jun; 13(6):887-98. PubMed ID: 16614880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging: what makes sense? Can the pathologist help?
    Bernick PE; Wong WD
    Surg Oncol Clin N Am; 2000 Oct; 9(4):703-20; discussion 721-3. PubMed ID: 11008235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10: 917-923, 2001.
    Dolcetti R; Guidoboni M; Viel A; Boiocchi M
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):499; author reply 499-500. PubMed ID: 12010867
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant treatment of stage II colon cancer: is there a true no-chemotherapy group?
    Martin RC
    Ann Surg Oncol; 2006 Jun; 13(6):766-7. PubMed ID: 16703279
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular profiling and risk stratification of adenocarcinoma of the colon.
    Mutch MG
    J Surg Oncol; 2007 Dec; 96(8):693-703. PubMed ID: 18081153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of blood levels of E-cadherin for diagnosis of colonic cancer].
    Sugawara Y; Ouchi K; Ono H; Kamiyama Y; Fujitani T; Kadokawa Y; Mikuni J; Yamanami H
    Nihon Geka Gakkai Zasshi; 1998 Apr; 99(4):273. PubMed ID: 9750074
    [No Abstract]   [Full Text] [Related]  

  • 12. [An angiogenesis study of Dukes' B colonic tumors].
    Pantalone D; Ziche M; Messerini L; Pazzagli M; Morbidelli L; Parenti A; Donnini S; Palomba AR; Tricarico C; Paolucci R; Taruffi F; Andreoli F
    Clin Ter; 1999; 150(5):331-7. PubMed ID: 10687262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
    Li M; Li JY; Zhao AL; Gu J
    Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cancer of the colon: an update].
    Fabre E; Spano JP; Atlan D; Braud AC; Mitry E; Panis Y; Faivre J
    Bull Cancer; 2000 Sep; Suppl 4():5-20. PubMed ID: 11072221
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
    Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
    J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer of the colon. Epidemiology, pathologic anatomy, Dukes staging, physiopathology, diagnosis, course, principles of treatment and prevention].
    Rougier P; Clavero-Fabri MC; Mitry E
    Rev Prat; 1999 Apr; 49(7):789-93. PubMed ID: 10337227
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NM23 expression as prognostic factor in colorectal carcinoma.
    Forte A; D'Urso A; Gallinaro LS; Lo Storto G; Soda G; Bosco D; Bezzi M; Vietri F; Beltrami V
    G Chir; 2002 Mar; 23(3):61-3. PubMed ID: 12109225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology, clinical presentation, and management of colon cancer.
    Cappell MS
    Gastroenterol Clin North Am; 2008 Mar; 37(1):1-24, v. PubMed ID: 18313537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic stratification of Dukes B colon cancer by a neoglycoprotein.
    Legendre H; Decaestecker C; Goris Gbenou M; Nagy N; Hendlisz A; André S; Pector JC; Kiss R; Gabius HJ
    Int J Oncol; 2004 Aug; 25(2):269-76. PubMed ID: 15254722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.